We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
+7.01%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$11.7B
AUM Growth
+$679M
Cap. Flow
+$28.6M
Cap. Flow %
0.24%
Top 10 Hldgs %
14.85%
Holding
1,328
New
71
Increased
347
Reduced
587
Closed
69

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$41.2M
2
GILD icon
Gilead Sciences
GILD
+$37M
3
ABBV icon
AbbVie
ABBV
+$35.6M
4
EXC icon
Exelon
EXC
+$33.2M
5
JNJ icon
Johnson & Johnson
JNJ
+$32.6M

Sector Composition

Rank Sector Weight
1 Technology 17.91%
2 Financials 17.7%
3 Healthcare 14.21%
4 Industrials 10.49%
5 Consumer Discretionary 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPC icon
676
Genuine Parts
GPC
$17.2B
$1.44M 0.01%
15,193
-2,296
-13% -$210K
APA icon
677
APA Corp
APA
$12.8B
$1.44M 0.01%
34,163
-8,732
-20% -$367K
DNR
678
DELISTED
Denbury Resources, Inc.
DNR
$1.44M 0.01%
651,020
+205,723
+46% +$323K
STMP
679
DELISTED
Stamps.com, Inc.
STMP
$1.44M 0.01%
7,655
+3,353
+78% +$648K
CTAS icon
680
Cintas
CTAS
$82.7B
$1.44M 0.01%
36,908
-20,348
-36% -$774K
CUBI icon
681
Customers Bancorp
CUBI
$2.65B
$1.44M 0.01%
55,219
+11,318
+26% +$321K
PRSU
682
Pursuit Attractions and Hospitality Inc
PRSU
$1.4B
$1.43M 0.01%
25,741
TILE icon
683
Interface
TILE
$1.96B
$1.42M 0.01%
56,596
+16,716
+42% +$392K
MNTA
684
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.42M 0.01%
101,844
+44,045
+76% +$595K
LBRDK icon
685
Liberty Broadband Class C
LBRDK
$4.79B
$1.42M 0.01%
16,671
AEE icon
686
Ameren
AEE
$30.1B
$1.42M 0.01%
24,054
-8,118
-25% -$499K
RH icon
687
RH
RH
$3.15B
$1.42M 0.01%
16,444
ULTA icon
688
Ulta Beauty
ULTA
$22.2B
$1.42M 0.01%
6,341
-1,797
-22% -$380K
MDCO
689
DELISTED
Medicines Co
MDCO
$1.42M 0.01%
51,830
-97,269
-65% -$3M
BCC icon
690
Boise Cascade
BCC
$2.65B
$1.41M 0.01%
35,336
MED icon
691
Medifast
MED
$110M
$1.41M 0.01%
20,198
SXC icon
692
SunCoke Energy
SXC
$717M
$1.41M 0.01%
117,360
-20,287
-15% -$219K
EBIX
693
DELISTED
Ebix Inc
EBIX
$1.41M 0.01%
17,757
LEA icon
694
Lear
LEA
$7.33B
$1.41M 0.01%
7,953
-804
-9% -$141K
EVR icon
695
Evercore
EVR
$12.1B
$1.4M 0.01%
15,585
RMBS icon
696
Rambus
RMBS
$9.72B
$1.39M 0.01%
97,752
CCK icon
697
Crown Holdings
CCK
$12.9B
$1.39M 0.01%
24,657
-487
-2% -$28.8K
EXPD icon
698
Expeditors International
EXPD
$21.8B
$1.39M 0.01%
21,447
-8,740
-29% -$536K
HRI icon
699
Herc Holdings
HRI
$4.88B
$1.38M 0.01%
21,982
ACOR
700
DELISTED
Acorda Therapeutics
ACOR
$1.37M 0.01%
533

Similar funds

KBC Group's Q4 2017 Portfolio in Review

As of Q4 2017, KBC Group held 1,328 positions worth $11.7B, up 6.2% from $11B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

KBC Group's Q4 2017 filing shows 71 new, 347 increased, 587 reduced and 69 closed positions. Its largest new stake was Coca-Cola Europacific Partners: 311,633 shares worth $12.4M. The largest sale was Celgene Corp, an estimated $41.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • KBC Group's largest Q4 2017 buy was Coca-Cola Europacific Partners: 311,633 shares worth $12.4M.
  • KBC Group added most to Lam Research in Q4 2017, an estimated $54.8M increase.
  • KBC Group's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $41.2M.
  • KBC Group fully exited Gulfport Energy Corp. in Q4 2017, selling an estimated $2.72M.
  • KBC Group's ten largest holdings make up 15% of its $11.7B portfolio in Q4 2017.
  • KBC Group opened 71 new positions and closed 69 in Q4 2017.
  • KBC Group's portfolio value rose 6.2% quarter-over-quarter to $11.7B.

Based on KBC Group's 13F filing for Q4 2017, filed 7 Feb 2018.